Barrier Therapeutics to Present at the CIBC World Markets Annual Biotechnology and Specialty Pharmaceuticals Conference

The i-Technology Media!	Register \| Log in

.NET · AJAX · CLOUD · ECLIPSE · FLEX · OPEN WEB · iPHONE · JAVA · LINUX · OPEN SOURCE · ORACLE · PBDJ · SEARCH · SILVERLIGHT · SOA · VIRTUALIZATION · WEB 2.0 · WIRELESS · XML

Comments

Plone and Drupal: Different Approaches, Different Results

paul.nowak wrote: Matt, thanks for the comments. I made an error on the version of Plone. It's 2.5 Plone running on Zope 2.9x. In regards to the additional products, we have a skin installed and we have a product that we had custom developed for us that connects to a PostgreSQL database. We've looked at slow PostgreSQL queries causing problems and have not been able to find an issue. We've also tested for the case where the PostgreSQL server is down and have not been able to create an issue. We therefor...

Nov. 4, 2009 04:19 PM EST

Cloud Expo on Google News

Did you read today's front page stories & breaking news?

2009 East

PLATINUM SPONSORS:

IBM

Smarter Business Solutions Through Dynamic Infrastructure

IBM

Smarter Insights: How the CIO Becomes a Hero Again

Microsoft

Windows Azure

GOLD SPONSORS:

Appsense

Why VDI?

Maximizing the Business Value of Virtualization in Enterprise and Cloud Computing Environments

ExactTarget

Messaging in the Cloud - Email, SMS and Voice

Freedom OSS

Stairway to the Cloud

Sun

Sun's Incubation Platform: Helping Startups Serve the Enterprise

POWER PANELS:

Cloud Computing & Enterprise IT: Cost & Operational Benefits

How and Why is a Flexible IT Infrastructure the Key To the Future?

Click For 2008 West
Event Webcasts

2009 East

GOLD SPONSORS:

Get Your Transactions Under Control: SOA Performance Management

Software AG

Performance Driven Adoption: The Secret to Advancing SOA

Intel

The Evolving SOA Appliance: 3 Game-Changing Innovations

SILVER SPONSOR:

Denodo

Data Mashups: Deliver Your Project Faster with Virtualized Data Services Across Internal & External Sources

POWER PANELS:

The Business Value of Service Orientation

Driving Profitability Through User Experience

Click For 2008 West
Event Webcasts

Live Google News by SYS-CON!

Top Three Links You Must Click On

From the Wires

Barrier Therapeutics to Present at the CIBC World Markets Annual Biotechnology and Specialty Pharmaceuticals Conference

By: Marketwire .

Apr. 5, 2007 11:30 AM

PRINCETON, NJ -- (MARKET WIRE) -- 04/05/07 -- Barrier Therapeutics, Inc. (NASDAQ: BTRX), a pharmaceutical company that develops and markets dermatology products, today announced that Dr. Geert Cauwenbergh, Chief Executive Officer, will participate in the CIBC World Markets Annual Biotechnology and Specialty Pharmaceuticals Conference.

The conference will be held at the Millennium Broadway Hotel in New York, NY on April 11 - April 12, 2007. Barrier Therapeutics is scheduled to present on Thursday, April 12, at 9:10 a.m. EDT (6:10 a.m. PDT).

The presentation will be available via a live webcast and can be accessed through the Investor Relations section of Barrier Therapeutics' corporate website at: www.barriertherapeutics.com. An archive of the presentation will be available for replay for 90 days.

About Barrier Therapeutics

Barrier Therapeutics, Inc. is a pharmaceutical company focused on the development and commercialization of products in the field of dermatology. Barrier Therapeutics currently markets three pharmaceutical products in the United States: Xolegel(TM) (ketoconazole, USP) Gel, 2%, for seborrheic dermatitis; Vusion(TM) (0.25% miconazole nitrate, 15% zinc oxide, 81.35% white petrolatum) Ointment, for diaper dermatitis complicated by documented candidiasis; and Solagé® (mequinol 2.0%, tretinoin 0.01%) Topical Solution, for solar lentigines. Barrier Therapeutics has other product candidates in various stages of clinical development for the treatment of a range of dermatological conditions, including onychomycosis, psoriasis, acne, skin allergies, and acute fungal infections. The company is headquartered in Princeton, New Jersey and has wholly owned subsidiaries in Geel, Belgium and Ontario, Canada. More information about Barrier Therapeutics can be found on its corporate website at: www.barriertherapeutics.com.

Xolegel, Vusion and Solagé are trademarks of Barrier Therapeutics, Inc.

Contact:
Barrier Therapeutics, Inc.
Anne M. VanLent
EVP & CFO
(609) 945-1202

Lazar Partners Ltd.
Gregory Gin, Investor Relations
(212) 867-1762

Published Apr. 5, 2007— Reads 302
Copyright © 2007 SYS-CON Media, Inc. — All Rights Reserved.
Syndicated stories and blog feeds, all rights reserved by the author.

About Marketwire .
Copyright © 2009 Marketwire. All rights reserved. All the news releases provided by Market Wire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.